Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.7K Sell
252
-60
-19% -$12.3K 0.02% 163
2025
Q4
$79.9K Sell
312
-47
-13% -$12.3K 0.03% 154
2025
Q3
$93.4K Buy
+359
New +$94.4K 0.03% 154
2024
Q1
Sell
-339
Closed -$155K 355
2023
Q4
$155K Sell
339
-44
-11% -$21.7K 0.04% 310
2023
Q3
$186K Sell
383
-40
-9% -$18.8K 0.05% 267
2023
Q2
$189K Sell
423
-18
-4% -$9.06K 0.05% 262
2023
Q1
$214K Sell
441
-47
-10% -$23.2K 0.07% 208
2022
Q4
$250K Buy
488
+46
+10% +$24.2K 0.09% 187
2022
Q3
$214K Sell
442
-86
-16% -$41.8K 0.08% 196
2022
Q2
$247K Sell
528
-537
-50% -$239K 0.09% 195
2022
Q1
$463K Sell
1,065
-951
-47% -$398K 0.18% 89
2021
Q4
$935K Buy
2,016
+1,034
+105% +$458K 0.22% 81
2021
Q3
$382K Sell
982
-827
-46% -$351K 0.14% 71
2021
Q2
$801K Buy
1,809
+305
+20% +$133K 0.24% 88
2021
Q1
$631K Buy
+1,504
New +$600K 0.22% 91

Other funds holding HUM

AXS Investments's HUM Position: Q1 2026 in Review

AXS Investments reduced its Humana (HUM) stake by 19% in Q1 2026, selling an estimated $12.3K and leaving 252 shares worth $43.7K. The position accounts for 0.02% of the portfolio, ranked #163.

AXS Investments first reported a position in HUM in Q1 2021 and has held it in 15 quarters since. The position peaked at $935K in Q4 2021. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • AXS Investments held 252 shares of Humana worth $43.7K as of Q1 2026.
  • AXS Investments sold 60 Humana shares in Q1 2026, an estimated $12.3K.
  • Humana made up 0.02% of AXS Investments's portfolio in Q1 2026, its #163 holding.
  • AXS Investments first reported a position in Humana in Q1 2021 and has held it in 15 quarters since.
  • AXS Investments's Humana position peaked at $935K in Q4 2021.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.